Godavari Biorefineries Legal & Regulatory
Godavari Biorefineries received a Rs. 12.88 Crore demand notice from HESCOM for cross-subsidy charges on power imported between 2013-2016. The company is assessing the liability.
- Value
- ₹12.88 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
9 announcements with these filters
Godavari Biorefineries received a Rs. 12.88 Crore demand notice from HESCOM for cross-subsidy charges on power imported between 2013-2016. The company is assessing the liability.
China's patent office granted Godavari Biorefineries a patent for compounds treating viral infections. The invention covers V-ATPase inhibition for medicament use.
Godavari Biorefineries Ltd has been granted a patent by the European Patent Office for its 'A Biofiller for Rubber Reinforcement' technology.
Godavari Biorefineries Limited submitted its 2025-26 Annual Report, prior to the 71st Annual General Meeting scheduled for September 28, 2026.
Godavari Biorefineries Ltd issued the notice for its 71st Annual General Meeting, scheduled for September 28, 2026, via video conferencing.
Godavari Biorefineries Ltd received a show-cause notice from the Karnataka Commercial Tax Department for GST-related short payments totaling approximately ₹18.13 Crore.
Godavari Biorefineries received a GST show-cause notice of ₹17.02 Crore for the period 2021-2024. The company is evaluating the claim and preparing its legal response.
Q1 FY27 revenue grew 4.6% to ₹557.9 Cr, but EBITDA fell to ₹2.6 Cr. Performance was pressured by high inventory costs and raw material prices despite strong chemical segment growth.
Godavari Biorefineries received a European patent for an anti-cancer pharmaceutical composition. This grant strengthens the company's oncology-focused intellectual property portfolio and therapeutic potential.